qwertyuiopasdfghjklzxcvbnmqwerty uiopasdfghjklzxcvbnmqwertyuiopasd fghjklzxcvbnmqwertyuiopasdfghjklzx cvbnmqwertyuiopasdfghjklzxcvbnmq wertyuiopasdfghjklzxcvbnmqwertyui opasdfghjklzxcvbnmqwertyuiopasdfg hjklzxcvbnmqwertyuiopasdfghjklzxc vbnmqwertyuiopasdfghjklzxcvbnmq wertyuiopasdfghjklzxcvbnmqwertyui opasdfghjklzxcvbnmqwertyuiopasdfg NIFTY OUTLOOK hjklzxcvbnmqwertyuiopasdfghjklzxc REPORT vbnmqwertyuiopasdfghjklzxcvbnmq 11 July 2017 wertyuiopasdfghjklzxcvbnmqwertyui opasdfghjklzxcvbnmqwertyuiopasdfg hjklzxcvbnmrtyuiopasdfghjklzxcvbn mqwertyuiopasdfghjklzxcvbnmqwert yuiopasdfghjklzxcvbnmqwertyuiopas th
11th July 2017
NIFTY
NIFTY FUT : PIVOT : 9752
R1:9800 S1:9712
R2:9825 S2:9647
R3:9850 S3:9607
NIFTY INTRADAY CHART NIFTY OUTLOOK Nifty is likely to open in a marginal positive note. Momentum indicators are indicating towards a strong trading session for bulls. Bulls are ready to show their hidden power after bear losses 9675 mark. Positional traders are advised to cover their shorts as we are expecting nifty to show up 10,000 soon in upcoming trading sessions. Strategy: Buy nifty around 9760 with a stop loss of 9725 for the target of 9820.
Name
Current Value
Change
% Chg
Open
High
Low
FTSE 100 (Jul 10)
7,370.03
19.11
0.26
7,350.92
7,388.02
7,344.31
CAC 40 (Jul 10)
5,165.64
20.48
0.4
5,160.70
5,179.34
5,147.67
DAX (Jul 10)
12,445.92
57.24
0.46
12,464.96
12,482.95
12,406.20
20,173.21
92.23
0.46
20,073.86
20,179.78
20,070.67
3,234.11
-12.24
-0.38
3,248.55
3,249.49
3,230.58
25,784.22
284.16
1.1
25,605.19
25,788.99
25,596.21
10,385.81
95.9
0.92
10,313.08
10,392.25
10,313.08
9,793.50
20.5
0.21
9,776.00
9,807.50
9,759.00
Nikkei 225 (Jul 11) Straits Times (Jul 11) Hang Seng (Jul 11) Taiwan Weighted (Jul 11) SGX Nifty (Jul 11)
WWW.EQUITYRESEARCHLAB.COM
11th July 2017
CORPORATE NEWS -Cadila Healthcare: Zydus gets tentative US FDA nod for Lurasidone Hydrochloride tablets -Alembic Pharmaceuticals receives USFDA tentative approval for Dabigatran Etexilate capsules -SBI board approves divestment of SBI's stake in SBI Life through an IPO; offer for sale of 8 crore shares -Patel Integrated Logistics signs letter of intent to acquire a warehouse of 35000 square feet carpet area in Gujarat on 30-year lease basis with Sumar Logistics & Industrial Park -Gallantt Metal - Ind-Ra affirms A- rating to company's long term borrowing -Accel Frontline completes sale of entire shareholding in Accel systems, Singapore to Starhub -Ramco Systems - ICRA reaffirms the long term and short term credit ratings for bank facilities -Oriental Bank of Commerce revises 1-year MCLR rate to 8.45 percent from 8.5 percent -Global carriers, PE hover around Jet Airways to acquire 24 percent stake: ET -SpiceJet - Ex-promoter Maran alleges contract violation “no question of dmamges� -GTL comes clean in audit, lenders to settle debt: ET -DB Corp in talks to sell 2520MW power arm to Tata Power, CDPQ, ICICI venture: ET -Lanco Infratech encashes suppliers bank guarantees: BS -Inox Wind, Suzlon Energy in focus - GST concerns delay renewable auction in Gujarat: FE-IOC, Lanzatech sign statement of intent to construct gas-to-bioethol production unit in India
WWW.EQUITYRESEARCHLAB.COM
11th July 2017
ERL RESEARCH TEAM Member Name
Designation
E-mail ID
Mr. Tuhinanshu Jain Mr. Manish Bimal
Research Head Sr. Research Analyst
Tuhinanshu.jain@equityresearchlab.co.in Manish.bimal@equityresearchlab.co.in
DISCLAIMER The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Investment in Stocks has its own risks. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. We, however, do not vouch for the accuracy or the completeness thereof. This material is for personal information and we are not responsible for any loss incurred based upon it & takes no responsibility whatsoever for any financial profit s or loss which may arise from the recommendations above. The stock price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Equity Research Lab does not purport to be an invitation or an offer to buy or sell any financial instrument. Analyst or any person related to Equity Research Lab might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Any surfing and reading of the information is the acceptance of this disclaimer. Our Clients (Paid or Unpaid), any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken. Any surfing and reading of the information is the acceptance of this disclaimer. ALL RIGHTS RESERVED.
WWW.EQUITYRESEARCHLAB.COM